Digital Look

Welcome to Digital Look++,
you are not logged in

Haleon (HLN)

Pharma and Biotech

330.80p

Select chart: EPS | Dividend | Revenue

Period Ending	Period	Revenue (£m)	Pre-tax (£m)	EPS	Dividend
30-Jun-26	Interim	5,602.00	1,056.00	8.60p	2.40p

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-21	9,545.00	1,636.00	17.90p	n/a	n/a	n/a	n/a	0.0%
31-Dec-22	10,858.00	1,618.00	18.40p	17.8	5.9	+3%	2.40p	0.7%
31-Dec-23	11,302.00	1,628.00	11.40p	28.2	n/a	-38%	6.00p	1.9%
31-Dec-24	11,233.00	1,910.00	15.80p	23.9	0.6	+39%	6.60p	1.7%
31-Dec-25	11,030.00	2,152.00	18.60p	20.2	1.1	+18%	7.10p	1.9%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts data is not available for this company.

	5 Yr High	5 Yr Low	5 Yr Avg	Curr / Avg
Latest	17.79	17.79	n/a	0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

Find out about IFRS and how this affects the financial infomation for all UK companies.